The potential role of the 4CMenB vaccine in combating gonorrhoea: the need for nuance in interpreting the DOXYVAC trial

Lancet Infect Dis. 2024 Sep;24(9):e543. doi: 10.1016/S1473-3099(24)00452-3. Epub 2024 Jul 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Bacterial Vaccines / administration & dosage
  • Bacterial Vaccines / immunology
  • Gonorrhea* / drug therapy
  • Gonorrhea* / prevention & control
  • Humans
  • Male
  • Meningococcal Vaccines / administration & dosage
  • Meningococcal Vaccines / therapeutic use
  • Neisseria gonorrhoeae* / drug effects
  • Neisseria gonorrhoeae* / immunology

Substances

  • 4CMenB vaccine
  • Meningococcal Vaccines
  • Bacterial Vaccines